HCV-HIV Coinfection Guideline

January 2017

The Medical Care Criteria Committee of the New York State Department of Health (NYSDOH) AIDS Institute recommends that all HIV/HCV co-infected patients be considered candidates for hepatitis C treatment, regardless of fibrosis stage.

The NYSDOH AIDS Institute guideline on HIV-HCV coinfection is currently under revision, with expected publication in early 2017. For up-to-date information on hepatitic C treatment, see IDSA-AASLD Recommendations for Testing, Managing, and Treating Hepatitis C.